T1	Treatment 0 38	Salmeterol plus fluticasone propionate
T2	Treatment 46 86	fluticasone propionate plus montelukast:
T3	Treatment 492 551	salmeterol plus fluticasone propionate (FP) (Seretide; SFC)
T4	Treatment 556 582	FP plus montelukast (FP/M)
T5	Treatment 719 758	randomised to SFC or FP/M for 12 weeks.
T6	Treatment 1259 1262	SFC
T7	Treatment 1343 1348	FP/M.
T8	Treatment 1349 1353	FP/M
T9	Treatment 1432 1435	SFC
T10	Treatment 1616 1620	SFC.
